DOI: 10.3181/00379727-94-22963 View full text |Buy / Rent full text

Abstract: Intraperitoneal injections of glucagon and of epinephrine cause an immediate and marked reduction in liver glycogen ( 1,2), due to an increase in phosphorylase activity (3,4). This glycogenolytic phase is followed, 24 hours after glucagon and 2 hours after epinephrine, by marked increase in liver glycogen (1,5,6) and is accompanied by increase in adrenal weight and decrease in adrenal ascorbic acid. In alloxan diabetic rats, the glycogenolytic effect of glucagon and epinephrine appears to be unimpaired, but no… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles